PMC:7381711 / 19683-19930
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T172 | 66-73 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
| T173 | 207-214 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 670 | 66-73 | Chemical | denotes | heparin | MESH:D006493 |
| 671 | 207-214 | Chemical | denotes | heparin | MESH:D006493 |
| 677 | 143-155 | Disease | denotes | coagulopathy | MESH:D001778 |
| 678 | 159-175 | Disease | denotes | critical illness | MESH:D016638 |
| 679 | 218-226 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T164 | 143-155 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
| T165 | 218-226 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T219 | 66-73 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
| T220 | 207-214 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 0-247 | Sentence | denotes | Given the potential benefits (and uncertain risks) of therapeutic heparin (see Fig. 3), tempered by the failures of previous studies targeting coagulopathy in critical illness, randomized clinical trials of heparin in COVID-19 are urgently needed. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T44 | 143-155 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |